AI-generated summary
This review article describes the design, synthesis, and payload encapsulation strategies of upconversion nanoparticle-based delivery platforms for cancer therapy. The authors report that these platforms can use near-infrared light, which has lower phototoxicity and higher tissue penetration than UV or visible light, to trigger remote, spatially and temporally controlled release of therapeutic molecules. The abstract also notes that challenges remain for engineering such platforms.
- Limits stated in the abstract
- The abstract is a narrative review that reports no quantitative results, and it does not describe the number or quality of studies covered.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.